Adagio Therapeutics, Inc. |
Director, Other*, 10%+ Owner |
Common Stock |
11.2M |
$44.4M |
$3.95 |
Mar 28, 2022 |
Indirect |
Fractyl Health, Inc. |
Director, 10%+ Owner |
Common Stock |
1.25M |
$3.63M |
$2.90 |
Feb 6, 2024 |
Indirect |
Fractyl Health, Inc. |
Director, 10%+ Owner |
Stock Option |
45K |
|
|
Feb 1, 2024 |
Direct |
Adagio Therapeutics, Inc. |
Director, Other*, 10%+ Owner |
Stock Option (Right to Buy) |
35.6K |
|
|
Aug 5, 2021 |
Direct |
Adagio Therapeutics, Inc. |
Director, Other*, 10%+ Owner |
Series A Preferred Stock |
0 |
|
|
Aug 10, 2021 |
Indirect |
Adagio Therapeutics, Inc. |
Director, Other*, 10%+ Owner |
Series B Preferred Stock |
0 |
|
|
Aug 10, 2021 |
Indirect |
Adagio Therapeutics, Inc. |
Director, Other*, 10%+ Owner |
Series C Preferred Stock |
0 |
|
|
Aug 10, 2021 |
Indirect |
Fractyl Health, Inc. |
Director, 10%+ Owner |
Series C-1 Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Indirect |
Fractyl Health, Inc. |
Director, 10%+ Owner |
Series C-2 Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Indirect |
Fractyl Health, Inc. |
Director, 10%+ Owner |
Series D Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Indirect |
Fractyl Health, Inc. |
Director, 10%+ Owner |
Series E Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Indirect |
Fractyl Health, Inc. |
Director, 10%+ Owner |
Series F Preferred Stock |
0 |
|
|
Feb 6, 2024 |
Indirect |